Lextron, Inc, a Colorado-based distributor of livestock vaccines and supplements, announced its plans to buy competitor Animal Health International, Inc, for about US$251 million.
In a joint statement released this week the companies stated that privately-held Lextron will pay US$4.25 a share for all outstanding Animal Health stock or approximately US$111 million plus assume US$140 million of Animal Health’s debt.
According to John Adent, President and CEO for Lextron, “This merger provides an opportunity for us to collectively create the country’s premier animal health business.” Read more ...
This blog is written by Martin Little The Global Miller, published and supported by the GFMT Magazine from Perendale Publishers.
No comments:
Post a Comment